● Covered by 2 sources · 2 reportsMedium impact
Neko Health Raises $700 Million, Plans US Expansion with First Clinic in New York
Key points
- Neko Health raised $700 million in Series C funding.
- First US clinic to open in New York this year.
- Led by Lightspeed Venture Partners and O.G. Venture Partners.
- Uses AI for body scans detecting conditions like skin cancer.
- Plans further expansion in US after New York.
Neko Health Secures Major Funding
Neko Health, a healthcare startup co-founded by Spotify's Daniel Ek, has successfully raised $700 million in a Series C funding round. This substantial investment was led by Lightspeed Venture Partners and O.G. Venture Partners, following a $260 million Series B funding earlier. The new funds aim to enhance the company's health assessment technology and enable its expansion into the US market.
US Expansion Plans Announced
The startup, known for its AI-enabled body scans and blood tests, plans to open its first US clinic in New York later this year. This step is part of a broader strategy to establish a presence in the United States, building on existing operations in the UK and Sweden.
Neko Health's technology is designed to proactively detect health conditions, including skin cancer and heart disease, with the goal of preventing diseases and helping people lead longer lives.
Advancements in Health Assessment Technology
Neko Health's clinics offer comprehensive health assessments by integrating proprietary body scanning technology with blood tests and data from Apple Health. This holistic approach aims to provide medical clinicians with valuable real-world data to support their assessments.
More than 100,000 individuals have already utilized Neko Health's services, with over 350,000 on the waitlist or having set appointments, highlighting growing public interest in technology-driven preventive healthcare.
Significance of Technology-Driven Healthcare
The move into the US market marks a significant milestone for Neko Health as it looks to broaden its impact in preventive healthcare. By leveraging technology, the company seeks to provide early detection and treatment, potentially reducing the burden of serious health conditions.
This expansion could set a precedent for similar health-tech initiatives, promoting the integration of advanced technology in routine medical check-ups and potentially transforming preventive healthcare.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
How outlets covered it
Neko Health has secured $700 million in a Series C funding round to enhance its health assessment technology. This substantial investment will aid the company in expanding its services, including a planned entry into the U.S. market with its first location in New York.
Neko Health, co-founded by Spotify's Daniel Ek, plans to enter the US market after securing $700 million in funding. The startup intends to launch its first clinic in New York this year, focusing on preventive healthcare through AI-enabled body scans and blood tests.